Cart
sales@molnova.com
Hyaluronidase
CAS No. 37326-33-3
Hyaluronidase( Hyaluronate 4-glycanohydrolase,Hyaluronoglucosaminidase )
Catalog No. M22683 CAS No. 37326-33-3
Hyaluronidase is a naturally occurring enzyme that depolymerizes hyaluronic acid by cleavage of glycosidic bonds and has been utilized in ophthalmic surgery.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 50MG | 74 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHyaluronidase
-
NoteResearch use only, not for human use.
-
Brief DescriptionHyaluronidase is a naturally occurring enzyme that depolymerizes hyaluronic acid by cleavage of glycosidic bonds and has been utilized in ophthalmic surgery.
-
DescriptionHyaluronidase is a naturally occurring enzyme that depolymerizes hyaluronic acid by cleavage of glycosidic bonds and has been utilized in ophthalmic surgery.
-
In Vitro——
-
In Vivo——
-
SynonymsHyaluronate 4-glycanohydrolase,Hyaluronoglucosaminidase
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
IndicationDehydration
Chemical Information
-
CAS Number37326-33-3
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityH2O:100 mg/mL (Need ultrasonic)
-
SMILESN/A
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vartanian AJ, et al. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch Facial Plast Surg. 2005 Jul-Aug;7(4):231-7.
molnova catalog
related products
-
Salirasib
Salirasib(Ki=2.6 μM), an effective competitive prenylated protein methyltransferase (PPMTase) inhibitor, inhibits Ras methylation with potential antineoplastic activity.
-
R(+)-Gomisin M1
Gomisin M1 ((±)-Gomisin M1) is a potent anti-HIV agent with an EC50 of <0.65 μM.
-
AC-261066
AC-261066 is a retinoic acid beta2 (beta2) receptor agonist (pEC50: 8.0).
